<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00370799</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 10</org_study_id>
    <nct_id>NCT00370799</nct_id>
  </id_info>
  <brief_title>Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain</brief_title>
  <official_title>A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Caudal Epidural Injections in Lumbar Disc Herniations, Spinal Stenosis, Discogenic Pain, and Post-Lumbar Laminectomy Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pain Management Center of Paducah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pain Management Center of Paducah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate clinically significant improvements or lack thereof in the caudal epidural
      patients with our without steroids.

      To evaluate differences in outcomes in patients receiving steroids compared to those patients
      randomized to the local anesthetic group who did not receive steroids.

      To assess improvements among patients and compare steroid groups with each other and local
      anesthetic group.

      To evaluate and compare the adverse event profile in all patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with chronic low back pain of at least 6 months duration, non-responsive to
      conservative management with NSAIDS, physical therapy or chiropractic treatment exercises.

      A single-center, prospective, controlled, double blinded, randomized study of patients in 4
      groups.

        -  Group 1. local anesthetics only

        -  Group 2. local anesthetic with 6mg of non-particulate Celestone

        -  Group 3. local anesthetic with 6 mg of brand name Celestone

        -  Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol

      All patients will be unblinded in 12 months.

      Non-responsive patients will be unblinded after 3 months and will be crossed over to a
      different group
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate for differences between the patients in various groups in the physical function and pain at 1, 3, 6, and 12 months post treatment</measure>
    <time_frame>1,3,6,12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess adverse events in all four groups.</measure>
    <time_frame>1,3,6,12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>local anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1. local anesthetics only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with generic Celestone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2. local anesthetic with 6mg of non-particulate Celestone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with Celestone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 3. local anesthetic with 6 mg of brand nameCelestone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with DepoMedrol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal epidural injection</intervention_name>
    <description>group 1: Caudal epidural injection local anesthetics only</description>
    <arm_group_label>local anesthetic</arm_group_label>
    <other_name>Group 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with generic Celestone</intervention_name>
    <description>Group 2. Caudal Epidural Injection local anesthetic with 6mg of non-particulate Celestone</description>
    <arm_group_label>Local anesthetic with generic Celestone</arm_group_label>
    <other_name>Group 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with Celestone</intervention_name>
    <description>Group 3. Caudal Epidural Injection with local anesthetic with 6 mg of brand name Celestone</description>
    <arm_group_label>Local anesthetic with Celestone</arm_group_label>
    <other_name>Group 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with DepoMedrol</intervention_name>
    <description>Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol</description>
    <arm_group_label>Local anesthetic with DepoMedrol</arm_group_label>
    <other_name>Group 4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age

          -  History of chronic, function-limiting low back pain of at least 6 months duration

          -  Able to give voluntary, written informed consent to participate,

          -  Able to understand the investigation, cooperate with the procedures, and willing to
             return for follow-up

          -  No recent surgical procedures within last three months

        Exclusion Criteria:

          -  Cauda Equina symptoms and/or compressive radiculopathy

          -  Narcotic use of no greater than 100mg/day hydrocodone, 60mg Methadone. or 100mg
             morphine

          -  Uncontrolled major Depression or uncontrolled psychiatric disorder

          -  Uncontrolled or acute medical illnesses

          -  Chronic severe conditions that could interfere with outcome assessments

          -  Women who are pregnant or lactating

          -  Subjects who have participated in a clinical study with an investigational product
             within 30 days of enrollment

          -  Patients with multiple complaints involving concomitant hip osteoarthritis

          -  Inability to achieve proper positioning and inability to understand informed consent
             and protocol

          -  History of adverse reaction to local anesthetic or anti-inflammatory drugs and history
             of gastrointestinal bleeding or ulcers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laxmaiah Manchikanti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ambulatory Surgery Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ambulatory Surgery Center</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2006</study_first_submitted>
  <study_first_submitted_qc>August 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2006</study_first_posted>
  <last_update_submitted>August 14, 2013</last_update_submitted>
  <last_update_submitted_qc>August 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pain Management Center of Paducah</investigator_affiliation>
    <investigator_full_name>Laxmaiah Manchikanti, MD</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>Caudal Epidural injections</keyword>
  <keyword>lumbar disc herniation</keyword>
  <keyword>spinal stenosis</keyword>
  <keyword>discogenic pain</keyword>
  <keyword>post-lumbar laminectomy syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

